- Home
- MNR vs PRCT Comparison
MNR vs PRCT Comparison
Compare MNR & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNR | PRCT |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MNR | PRCT |
|---|---|---|
| Price | $12.30 | $34.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $21.00 | ★ $50.00 |
| AVG Volume (30 Days) | 418.9K | ★ 1.6M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | ★ 22.36% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $956,307,000.00 | $299,907,000.00 |
| Revenue This Year | $21.87 | $48.34 |
| Revenue Next Year | $28.20 | $29.35 |
| P/E Ratio | $13.31 | ★ N/A |
| Revenue Growth | 9.45 | ★ 50.07 |
| 52 Week Low | $10.93 | $27.80 |
| 52 Week High | $19.00 | $97.49 |
Technical Indicators
Market Signals| Indicator | MNR | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 54.75 | 55.69 |
| Support Level | $12.27 | $29.04 |
| Resistance Level | $12.26 | $38.11 |
| Average True Range (ATR) | 0.38 | 1.83 |
| MACD | 0.11 | 0.76 |
| Stochastic Oscillator | 76.97 | 60.14 |
Price Performance
Historical ComparisonAbout MNR Mach Natural Resources LP
Mach Natural Resources LP is an independent upstream oil and gas company. The company is focused on the acquisition, development and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas, and the panhandle of Texas.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.